Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
CLEAR Expands at Hartsfield-Jackson Atlanta International Airport, Now Offering Expedited Identity Verification at International Terminal
-
Movie "Soul Searching": Inheriting the Culture and Promoting the Protection of the Great Wall
-
Movie "Soul Searching": Inheriting the Culture and Promoting the Protection of the Great Wall
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Volex plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DIRECT LINE INSURANCE GROUP - Ordinary Shares
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Loungers plc
-
Michael Downey, Former Tennis Canada CEO, Appointed Chair of the greater’s Advisory Board
-
Liberty Gold Announces Initial Assay Results from Rangefront Step-out Exploration Drilling at Black Pine Oxide Gold Project, Idaho
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Symbotic Inc. (NASDAQ: SYM) Investors with losses to Contact the Firm
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Zeta Global Holdings Corporation (NYSE: ZETA) Investors with losses to Contact the Firm
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Qaunterix Corporation (NASDAQ: QTRX) Investors with losses to Contact the Firm
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages PACS Group, Inc. (NYSE: PACS) Investors with losses to Contact the Firm
-
EducationSuperHighway Urges Congress and the Trump Administration to Create a Broadband Affordability Program for Unconnected Households
-
Net Asset Value(s)
-
TRAINERS' HOUSE PLC’S FINANCIAL REPORTING IN 2025
-
Norsk Hydro: Status share buyback program
-
John Munday named CEO of Colliers UK
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
IREN prices upsized $400 million convertible notes offering
-
Form 8.3 - Aviva plc GB00BPQY8M80
-
TRREB: GTA Home Sales Up Substantially in November
-
Bybit at CRYPTO TALKS. VILNIUS Vol. 2: Shares Insights on Navigating MiCAR's Complexities
-
Identity Threat Detection and Response (ITDR) Adoption Grows Despite Organizational Hurdles
-
Bybit at CRYPTO TALKS. VILNIUS Vol. 2: Shares Insights on Navigating MiCAR's Complexities
-
Absolute Climate Launches the First Industry-Wide Standard to Accelerate Carbon Removal Market
-
Mimecast Named a Winner of 2024 Rising Star Technology Partner of the Year for EMEA at the AWS Partner Awards
-
Major shareholder announcement
-
Result of the auction of 0.25 per cent DGB 2033 and 0.25 per cent DGB 2052
-
The 2024 Dongguan Global Investment Promotion Conference Kicks Off on December 5
-
BasisPoint hits major growth milestones – over 250 clients and 25 staff
-
IRCA BNP Paribas Primary New Issues: NO STAB Notice
-
Viomi Technology Co., Ltd Appoints New President of Operations to Promote High-quality Business Development
-
Sonoco Completes Acquisition of Eviosys
-
Thermosome Initiates Final Dose Level in Phase I Trial of Lead Compound THE001
-
Himax Announces $20 Million Share Buyback Program
-
Vaisala launches robust ultrasonic wind sensor for optimized wind turbine and maritime performance
-
China-South Korea (Yancheng) Industrial Park Economic and Trade Cooperation Exchange Conference Held to Elevate Bilateral Partnership
-
Form 8.5 (EPT/RI) - NewRiver REIT Plc
-
Twelve Capital Review of the Atlantic Hurricane Season 2024
-
New fixed-rate bonds - Nykredit Realkredit A/S
-
Nexans secures important contract for offshore wind project in the southern North Sea
-
Municipality Finance issues a EUR 100 million tap under its MTN programme
-
Astro Armadillos Universe Launches $ASTROS Token to Power Its Web3 Ecosystem and Educational Revolution
-
Summary of the EfTEN EfTEN Real Estate Fund AS webinars
-
Syensqo launches the second tranche of its Share Buyback Program
-
Results of Fundraising
-
ASM announces outcome of preliminary assessment new export regulations
-
Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial


